Metered Dose InhalersNebulizers and VaporizersDry Powder InhalersAdministration, InhalationBronchodilator AgentsPowdersAerosolsAnti-Asthmatic AgentsEquipment DesignAsthmaChlorofluorocarbonsAerosol PropellantsPulmonary Disease, Chronic ObstructivePeak Expiratory Flow RateTechnology Assessment, BiomedicalAlbuterolAdrenergic beta-AgonistsInhalation SpacersBeclomethasoneBudesonideVital CapacityHydrocarbons, FluorinatedIpratropiumTreatment OutcomeRandomized Controlled Trials as TopicDevice ApprovalLungPregnadienediolsEthanolaminesTerbutalineFenoterolRespiratory System AgentsRespiratory TherapyForced Expiratory VolumeCross-Over StudiesEquipment SafetyParticle SizeChlorofluorocarbons, MethanePregnenedionesDouble-Blind MethodIntrauterine DevicesScopolamine DerivativesAndrostadienesAdrenal Cortex HormonesPatient Education as TopicDrug Delivery SystemsEquipment FailureDevice RemovalEquipment and SuppliesDrug CombinationsChemistry, PharmaceuticalTherapeutic EquivalencyCromolyn SodiumAdrenergic beta-2 Receptor AgonistsLung Diseases, ObstructivePatient ComplianceSeptal Occluder DeviceTechnology, PharmaceuticalHoarsenessCholinergic AntagonistsGlucocorticoidsInspiratory CapacityMicrofluidic Analytical TechniquesEquipment Failure AnalysisMaximal Expiratory Flow RateRespiratory Function TestsAnti-Inflammatory AgentsPatient PreferenceSelf AdministrationOzone DepletionSelf-Help DevicesAtropine DerivativesBronchial SpasmMedication AdherenceTechnetiumProstheses and ImplantsOptical DevicesInhalationIntrauterine Devices, CopperDrug Therapy, CombinationDrug Administration ScheduleBiological AvailabilitySpirometryCharcoalPatient SatisfactionTime FactorsMetaproterenolLab-On-A-Chip DevicesBronchoconstriction